HB920 | Maryland 2019 | Health Insurance - Pharmaceutical Manufacturers - Transparency and Reporting

Link to Summary Link to Summary

Link to Full Text Link to Full Text

On April 5, 2019 in the House:

Unfavorable Report by Health and Government Operations; Withdrawn

On February 13, 2019 in the House:

Hearing 3/06 at 1:00 p.m.

On February 8, 2019 in the House:

First Reading Health and Government Operations

Fiscal and Policy Note

15-1601 - Article - Insurance

April 5, 2019: House - Committee - Health and Government Operations

MD - Delegate Nicholaus R. Kipke (U)

Type:

Primary Sponsor

MD - Delegate Adrienne A. Jones (U)

MD - Delegate Andrew Cassilly (U)

MD - Delegate April Rose (U)

MD - Delegate Carl Anderton, Jr. (U)

MD - Delegate Christopher T. Adams (U)

MD - Delegate Jay Jalisi (U)

MD - Delegate Kathy Szeliga (U)

MD - Delegate Matthew Morgan (U)

MD - Delegate Michael E. Malone (U)

MD - Delegate Paul Corderman (U)

MD - Delegate Sid Saab (U)

MD - Delegate Steve Johnson (U)

MD - Delegate Susan K. McComas (U)

MD - Delegate Teresa E. Reilly (U)

MD - Health and Government Operations (House)

Show previous .

Participants:

{{ teamMember.name ? teamMember.name : teamMember.email | escapeHtml | nl2br | trustHTML }} {{ teamMember.name ? teamMember.name : teamMember.email | escapeHtml | nl2br | trustHTML }}

{{ teamMember.name ? teamMember.name : teamMember.email | escapeHtml | nl2br | trustHTML }}

{{discussion.createdAt}} | delete | deleting | edit | cancel

Nothing posted by your team.

Select categories:

Clear all

+ New Note

Maryland HB920

Health Insurance - Pharmaceutical Manufacturers - Transparency and Reporting

+ − Bill Search

Table of Contents

Tools

+ − Summary

+ − Full Text

+ − Actions (3)

+ − Analysis